7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Whitney MJ et al. | Leukemia inhibitory factor secretion is a predictor and indicator of early progenitor status in adult bone marrow stromal cells. | 2009 | Tissue Eng Part A | pmid:18637760 |
| Tortelli F et al. | Osteoblast and osteoclast differentiation in an in vitro three-dimensional model of bone. | 2009 | Tissue Eng Part A | pmid:19292676 |
| Palumbo S and Li WJ | Osteoprotegerin enhances osteogenesis of human mesenchymal stem cells. | 2013 | Tissue Eng Part A | pmid:23597005 |
| Lin TH et al. | NF-κB decoy oligodeoxynucleotide enhanced osteogenesis in mesenchymal stem cells exposed to polyethylene particle. | 2015 | Tissue Eng Part A | pmid:25518013 |
| Yuksel S et al. | Increased serum osteoprotegerin levels associated with decreased bone mineral density in familial Mediterranean fever. | 2009 | Tohoku J. Exp. Med. | pmid:19346738 |
| Hsu BG et al. | High Serum Osteoprotegerin Is Associated with Arterial Stiffness in Kidney Transplant Patients. | 2015 | Tohoku J. Exp. Med. | pmid:26156285 |
| Zheng CM et al. | Association between increased serum osteoprotegerin levels and improvement in bone mineral density after parathyroidectomy in hemodialysis patients. | 2012 | Tohoku J. Exp. Med. | pmid:22156488 |
| Brzóska MM and Rogalska J | Protective effect of zinc supplementation against cadmium-induced oxidative stress and the RANK/RANKL/OPG system imbalance in the bone tissue of rats. | 2013 | Toxicol. Appl. Pharmacol. | pmid:23726800 |
| Park SY et al. | Betulinic acid, a bioactive pentacyclic triterpenoid, inhibits skeletal-related events induced by breast cancer bone metastases and treatment. | 2014 | Toxicol. Appl. Pharmacol. | pmid:24463094 |
| Bilgir O et al. | Comparative levels of macrophage migration inhibitory factor, procalcitonin, osteoprotegerin, interleukin-8, hs-C reactive protein, D-dimer in febrile neutropenia, newly diagnosed cancer patients, and infectious fever. | 2012 | Transfus. Apher. Sci. | pmid:22079264 |
| Bargnoux AS et al. | Renal transplantation decreases osteoprotegerin levels. | 2006 | Transplant. Proc. | pmid:16980077 |
| Malyszko J et al. | Osteoprotegerin and its correlations with new markers of bone formation and bone resorption in kidney transplant recipients. | 2003 | Transplant. Proc. | pmid:14529897 |
| Mesquita M et al. | Osteoprotegerin and progression of coronary and aortic calcifications in chronic kidney disease. | 2010 | Transplant. Proc. | pmid:21094794 |
| Ricci P et al. | Imbalance of the osteoprotegerin/RANKL ratio in bone marrow microenvironment after allogeneic hemopoietic stem cell transplantation. | 2006 | Transplantation | pmid:17164716 |
| Meneghini M et al. | Calcium and osteoprotegerin levels predict the progression of the abdominal aortic calcifications after kidney transplantation. | 2013 | Transplantation | pmid:23812001 |
| Hu H et al. | Noninvasive detection of acute and chronic injuries in human renal transplant by elevation of multiple cytokines/chemokines in urine. | 2009 | Transplantation | pmid:19543058 |
| Scatena M and Giachelli C | The alpha(v)beta3 integrin, NF-kappaB, osteoprotegerin endothelial cell survival pathway. Potential role in angiogenesis. | 2002 | Trends Cardiovasc. Med. | pmid:11852256 |
| Nakashima T et al. | New insights into osteoclastogenic signaling mechanisms. | 2012 | Trends Endocrinol. Metab. | pmid:22705116 |
| Günther T and Schinke T | Mouse genetics have uncovered new paradigms in bone biology. | 2000 | Trends Endocrinol. Metab. | pmid:10856921 |
| Wada T et al. | RANKL-RANK signaling in osteoclastogenesis and bone disease. | 2006 | Trends Mol Med | pmid:16356770 |
| Stilgren LS et al. | [The cytokine system of bone tissue]. | 2005 | Ugeskr. Laeg. | pmid:15789838 |
| Horshuns'ka MIu et al. | [Biological role of fetuin A and its potential importance for prediction of cardiovascular risk in patients with type 2 diabetes mellitus]. | 2013 May-Jun | Ukr Biokhim Zh (1999) | pmid:23937044 |
| Renno AC et al. | Ultrasound therapy modulates osteocalcin expression during bone repair in rats. | 2012 | Ultrasonics | pmid:21820693 |
| Hayton MJ et al. | Involvement of adenosine 5'-triphosphate in ultrasound-induced fracture repair. | 2005 | Ultrasound Med Biol | pmid:16085103 |
| Sauer G et al. | [Pathophysiology of bone metastases in urologic carcinomas]. | 2007 | Urologe A | pmid:17632696 |
| Brown JM et al. | Osteoprotegerin and rank ligand expression in prostate cancer. | 2001 | Urology | pmid:11306358 |
| Muehling B et al. | Effect of statin therapy on serum activity of proteinases and cytokines in patients with abdominal aortic aneurysm. | 2008 | Vasc Health Risk Manag | pmid:19337556 |
| Benevolenskaia LI | [Issues of osteoporosis in present-day medicine]. | 2003 | Vestn. Akad. Med. Nauk SSSR | pmid:12934464 |
| Shumakov VI et al. | [The peculiarities of bone exchange disorder and its regulation in men after long terms following orthotopic heart transplantation and cadaveric kidney transplantation]. | 2006 | Vestn. Akad. Med. Nauk SSSR | pmid:17136849 |
| Spahni AI et al. | Immunohistochemical localization of RANK, RANKL and OPG in healthy and arthritic canine elbow joints. | 2009 | Vet Surg | pmid:19674422 |
| Elders RC et al. | Susceptibility of the C2 canine mastocytoma cell line to the effects of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). | 2009 | Vet. Immunol. Immunopathol. | pmid:19185923 |
| Booij-Vrieling HE et al. | Inflammatory cytokines and the nuclear vitamin D receptor are implicated in the pathophysiology of dental resorptive lesions in cats. | 2009 | Vet. Immunol. Immunopathol. | pmid:19556012 |
| Gu JH et al. | Effects of RANKL, osteoprotegerin, calcium and phosphorus on survival and activation of Muscovy duck osteoclasts in vitro. | 2009 | Vet. J. | pmid:18682334 |
| Ito R et al. | Expression of osteoprotegerin correlates with aggressiveness and poor prognosis of gastric carcinoma. | 2003 | Virchows Arch. | pmid:12838418 |
| Gibbons CL et al. | Osteoclast-like cells in soft tissue leiomyosarcomas. | 2010 | Virchows Arch. | pmid:20127110 |
| Ito S and Hata T | Crystal structure of RANK ligand involved in bone metabolism. | 2004 | Vitam. Horm. | pmid:15110169 |
| Hao C et al. | Modulation of TRAIL signaling complex. | 2004 | Vitam. Horm. | pmid:15110173 |
| Ivanov SD et al. | [Prognosis of efficacy of organ-saving treatment of invasive bladder cancer]. | 2006 | Vopr Onkol | pmid:17168368 |
| Gajewska J et al. | [The impairement of bone formation and resorption in 25-year-old man with neglected celiac disease]. | 2005 | Wiad. Lek. | pmid:16238129 |
| Sobańska I et al. | [The influence of sex and age on the osteoprotegerin level in the blood]. | 2007 | Wiad. Lek. | pmid:17966895 |
| Wagner D and Fahrleitner-Pammer A | Levels of osteoprotegerin (OPG) and receptor activator for nuclear factor kappa B ligand (RANKL) in serum: are they of any help? | 2010 | Wien Med Wochenschr | pmid:20714810 |
| Winzer M et al. | Glycitein decreases the generation of murine osteoclasts and increases apoptosis. | 2010 | Wien Med Wochenschr | pmid:20714813 |
| Gruber R | Cell biology of osteoimmunology. | 2010 | Wien Med Wochenschr | pmid:20714814 |
| Malliga DE et al. | The role of osteoprotegerin (OPG) receptor activator for nuclear factor kappaB ligand (RANKL) in cardiovascular pathology - a review. | 2011 | Wien Med Wochenschr | pmid:21870142 |
| Beke D et al. | [Clinical relevance of biomarkers in cancer related bone disease]. | 2007 | Wien Med Wochenschr | pmid:17922085 |
| Kerschan-Schindl K | Bone turnover in hyperparathyroidism. | 2013 | Wien Med Wochenschr | pmid:22805761 |
| Fahrleitner-Pammer A et al. | Osteoprotegerin serum levels in women: correlation with age, bone mass, bone turnover and fracture status. | 2003 | Wien. Klin. Wochenschr. | pmid:12793029 |
| Fahrleitner A et al. | Serum osteoprotegerin levels in patients after liver transplantation and correlation to bone turnover, bone mineral density and fracture status. | 2002 | Wien. Klin. Wochenschr. | pmid:12602117 |
| Sood SK et al. | Osteoprotegerin (OPG) and related proteins (RANK, RANKL and TRAIL) in thyroid disease. | 2011 | World J Surg | pmid:21748518 |
| Larussa T et al. | No evidence of circulating autoantibodies against osteoprotegerin in patients with celiac disease. | 2012 | World J. Gastroenterol. | pmid:22529691 |